CEO: Barry D. Quart

Sector: Healthcare

Exchange: NASDAQ Capital Market

Country: USA

Description: Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.


Key numbers

Market Capitalization:1722429280
Shares Outstanding: 79816000
Float: 79494660.78400001
Next Earning Date:2020-03-02
TTm EPS: -2.4898
TTm Dividend Rate:
200 days moving average:20.6
50 days moving average: 19.67
One day percent Change: 7.26



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,